Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABBR2 | O75899 | 1/20 | 0.48 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | CPA1 | P15085 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | SRC | P12931 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CPB1 | P15086 | 1/20 | 0.40 |
| ▸ | CPA3 | P15088 | 1/20 | 0.40 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1171114 | 0.94 | GABBR2 (0.53) | GABBR2GABBR1CYP2C19CPA1CYP2D6 | |
| Hydrogen Sulfide SCHEMBL28282419 | 0.92 | GABBR2 (0.52) | GABBR2GABBR1CYP2C19CPA1CYP2D6 | |
| Di(Hydroxyethyl)Ether SCHEMBL1171208 | 0.88 | GABBR2 (0.42) | GABBR2GABBR1CYP2C19CPA1CYP2D6 | |
| SCHEMBL1171222 | 0.87 | GABBR2 (0.44) | GABBR2GABBR1CYP2C19CPA1CYP2D6 | |
| Glycerin SCHEMBL3210246 | 0.87 | GABBR2 (0.44) | GABBR2GABBR1CYP2C19CPA1MAPT | |
| SCHEMBL1303811 | 0.87 | GABBR2 (0.44) | GABBR2GABBR1CYP2C19CPA1CYP2D6 | |
| Glycerin SCHEMBL3192940 | 0.87 | GABBR2 (0.44) | GABBR2GABBR1CYP2C19CPA1MAPT | |
| SCHEMBL1171446 | 0.87 | GABBR2 (0.44) | GABBR2GABBR1CYP2C19CPA1CYP2D6 | |
| Propylene Glycol SCHEMBL1171246 | 0.85 | GABBR2 (0.43) | GABBR2GABBR1CYP2C19MAPTFFAR1 | |
| SCHEMBL999962 | 0.85 | GABBR2 (0.42) | GABBR2GABBR1CYP2C19CYP2D6LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12492293-B2 | Multi-component systems for preparing foamed products | ARKEMA FRANCE (FR) | 2025-12-09 | — | — | US | disclosed |
| US-20250154361-A1 | RECESS FILLING MATERIAL KIT, CURED PRODUCT THEREOF, AND RECESS FILLING METHOD | RESONAC CORPORATION (JP) | 2025-05-15 | — | — | US | disclosed |
| EP-4328206-A1 | RECESS FILLING MATERIAL KIT, CURED PRODUCT OF SAME, AND RECESS FILLING METHOD | Resonac Corporation (JP) | 2024-02-28 | — | — | EP | disclosed |
| EP-3891210-B1 | MULTI-COMPONENT SYSTEMS FOR PREPARING FOAMED PRODUCTS | ARKEMA FRANCE (FR) | 2023-08-23 | — | — | EP | disclosed |
| US-20230099722-A1 | COMPOSITION FOR FORMING THERMALLY CONDUCTIVE MATERIAL, THERMALLY CONDUCTIVE MATERIAL, THERMALLY CONDUCTIVE SHEET, AND DEVICE WITH THERMALLY CONDUCTIVE LAYER | FUJIFILM CORPORATION (JP) | 2023-03-30 | — | — | US | disclosed |
| EP-4024445-A1 | COMPOSITION FOR FORMING HEAT-CONDUCTING MATERIAL, HEAT-CONDUCTING MATERIAL, HEAT-CONDUCTING SHEET, AND DEVICE WITH HEAT-CONDUCTING LAYER | FUJIFILM Corporation (JP) | 2022-07-06 | — | — | EP | disclosed |
| US-20220033606-A1 | MULTI-COMPONENT SYSTEMS FOR PREPARING FOAMED PRODUCTS | ARKEMA FRANCE (FR) | 2022-02-03 | — | — | US | disclosed |
| EP-3891210-A1 | MULTI-COMPONENT SYSTEMS FOR PREPARING FOAMED PRODUCTS | ARKEMA FRANCE (FR) | 2021-10-13 | — | — | EP | disclosed |
| EP-3533809-B1 | RADICAL-POLYMERIZABLE RESIN COMPOSITION | SHOWA DENKO KK (JP) | 2021-09-29 | — | — | EP | disclosed |
| US-11130891-B2 | Photocurable sealing material | BOSTIK SA (FR) | 2021-09-28 | — | — | US | disclosed |
| EP-2295481-A1 | CURABLE COMPOSITION CONTAINING A REACTIVE (METH)ACRYLATE POLYMER AND A CURED PRODUCT THEREOF | Showa Denko K.K. (JP) | 2011-03-16 | — | — | EP | disclosed |
| US-7888399-B2 | Curable composition containing thiol compound | SHOWA DENKO K.K. (JP) | 2011-02-15 | — | — | US | disclosed |
| US-20100210812-A1 | CURABLE COMPOSITION AND CURED PRODUCT THEREOF | SHOWA DENKO K.K. (JP) | 2010-08-19 | — | — | US | disclosed |
| US-20100087611-A1 | URETHANE COMPOUND, CURABLE COMPOSITION CONTAINING THE SAME, AND CURED PRODUCT THEREOF | SHOWA DENKO K.K. (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-2172509-A1 | CURABLE COMPOSITION AND CURED PRODUCT THEREOF | Showa Denko K.K. (JP) | 2010-04-07 | — | — | EP | disclosed |
| US-20100029876-A1 | POLYMERIZATION ACCELERATOR, CURABLE COMPOSITION, CURED PRODUCT, AND PROCESS FOR PRODUCING THIOL COMPOUND | SHOWA DENKO K.K. (JP) | 2010-02-04 | — | — | US | disclosed |
| EP-2143739-A1 | URETHANE COMPOUND, CURABLE COMPOSITION CONTAINING THE SAME, AND CURED PRODUCT OF THE COMPOSITION | Showa Denko K.K. (JP) | 2010-01-13 | — | — | EP | disclosed |
| EP-2030989-A1 | POLYMERIZATION ACCELERATOR, CURABLE COMPOSITION, CURED PRODUCT AND METHOD FOR PRODUCING THIOL COMPOUND | Showa Denko K.K. (JP) | 2009-03-04 | — | — | EP | disclosed |
| US-20090023831-A1 | Curable Composition Containing Thiol Compound | SHOWA DENKO K.K. (JP) | 2009-01-22 | — | — | US | disclosed |
| EP-1983017-A1 | CURABLE COMPOSITION CONTAINING THIOL COMPOUND | Showa Denko K.K. (JP) | 2008-10-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087611-A1 | URETHANE COMPOUND, CURABLE COMPOSITION CONTAINING THE SAME, AND CURED PRODUCT THEREOF | ITCH, GLI1, UNC119 | GABBR2 734/4885GABBR1 497/4885CYP2C19 1723/4885 |
| US-20100029876-A1 | POLYMERIZATION ACCELERATOR, CURABLE COMPOSITION, CURED PRODUCT, AND PROCESS FOR PRODUCING THIOL COMPOUND | TMT1A, CCNT1, MGMT | GABBR2 4091/4885GABBR1 4296/4885CYP2C19 3376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.